Mechanisms of aluminium neurotoxicity in oxidative stress-induced ...
Mechanisms of aluminium neurotoxicity in oxidative stress-induced ...
Mechanisms of aluminium neurotoxicity in oxidative stress-induced ...
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
REFERENCES<br />
Sjögren B., El<strong>in</strong>der C. G., Iregren A., McLachlan D. R. C. and Riihimaki V. (1997) Occupational<br />
<strong>alum<strong>in</strong>ium</strong> exposure and its health effects, <strong>in</strong> Research issues <strong>in</strong> alum<strong>in</strong>um toxicity (Yokel R.<br />
A. and Golub M. S., eds), pp. 165–183, Taylor and Francis, Wash<strong>in</strong>gton DC.<br />
Smith P. D., Mount M. P., Shree R., Callaghan S., Slack R. S., Anisman H., V<strong>in</strong>cent I., Wang X.,<br />
Mao Z. and Park D. S. (2006) Calpa<strong>in</strong>-regulated p35/cdk5 plays a central role <strong>in</strong><br />
dopam<strong>in</strong>ergic neuron death through modulation <strong>of</strong> the transcription factor myocyte<br />
enhancer factor 2. J. Neurosci. 26, 440–447.<br />
Smith W. W., Pei Z., Jiang H., Dawson V. L., Dawson T. M. and Ross C. A. (2006) K<strong>in</strong>ase activity<br />
<strong>of</strong> mutant LRRK2 mediates neuronal toxicity. Nat. Neurosci. 9, 1231–1233.<br />
S<strong>of</strong>ic E., Paulus W., Jell<strong>in</strong>ger K., Riederer P. and Youdim M. B. (1991) Selective <strong>in</strong>crease <strong>of</strong> iron<br />
<strong>in</strong> substantia nigra zona compacta <strong>of</strong> park<strong>in</strong>sonian bra<strong>in</strong>s. J. Neurochem. 56, 978–982.<br />
S<strong>of</strong>ic E., Lange K. W., Jell<strong>in</strong>ger K. and Riederer P. (1992) Reduced and oxidized glutathione <strong>in</strong><br />
the substantia nigra <strong>of</strong> patients with Park<strong>in</strong>son's disease. Neurosci. Lett. 142, 128–130.<br />
S<strong>of</strong>ic E., Riederer P., He<strong>in</strong>sen H., Beckmann H., Reynolds G. P., Hebenstreit G. and Youdim M.<br />
B. (1988) Increased iron (III) and total iron content <strong>in</strong> post mortem substantia nigra <strong>of</strong><br />
park<strong>in</strong>sonian bra<strong>in</strong>. J. Neural. Transm. 74, 199–205.<br />
Soni M. G., White S. M., Flamm W.G. and Burdock G. A. (2001) Safety evaluation <strong>of</strong> dietary<br />
alum<strong>in</strong>um. Regul Toxicol Pharmacol. 33, 66–79.<br />
Sorenson J. R., Campbell I. R., Tepper L. B. and L<strong>in</strong>gg R. D. (1974) Alum<strong>in</strong>um <strong>in</strong> the environment<br />
and human health. Environ. Health. Perspect. 8, 3–95.<br />
Soto-Otero R., Méndez-Álvarez E., Hermida-Ameijeiras A., Muñoz-Patiño A. M. and Labandeira-<br />
García J. L. (2000) Autoxidation and <strong>neurotoxicity</strong> <strong>of</strong> 6-hydroxydopam<strong>in</strong>e <strong>in</strong> the presence<br />
<strong>of</strong> some antioxidants: potential implication <strong>in</strong> relation to the pathogenesis <strong>of</strong> Park<strong>in</strong>son’s<br />
disease. J. Neurochem. 74, 1605–1612.<br />
Soto-Otero R., Méndez-Álvarez M., Hermida-Ameijeiras A., Sánchez-Sellero I., Cruz-Landeira A.<br />
and López-Rivadulla Lamas M. (2001) Inhibition <strong>of</strong> bra<strong>in</strong> monoam<strong>in</strong>e oxidase activity by<br />
237